Overview Company Profile Presentation Company Presentation Reports Immediate Reports Financial Financial Reports Management Management Stock Stock Chart FAQ FAQ Alert Mail Alert Contact Contact IR Stock Quote Tel Aviv: MRHL 93.9 Price -2.8% Change percentage -2.7 Change 92.9 90 Last Update:28/02/2021 at:13:45 Presentations Investors Presentation - virtual investor conference to be held on 24.2.21 Investors Presentation - May 2020 - Hebrew Investors Presentation - December 2019 (H) Financial Reports 2nd Quarter 2020 4th Quarter 2019 Immediate Reports Cardiacsense (approximately 5.67%), Receives CE approval for the marketing of a medical watch that it opened in Europe, expected date for FDA approval 10/02/2021 The investment of $ 150k as part of an investment round of about $ 17k in CDX according to about $ 112k (after), will hold 6.64% 07/02/2021 A round of fundraising in Cardiacsense (about 5.8%) – the debtor will invest $ 250, hold about 5.95% of the capital, B. Control will participate 04/02/2021 EFA (approximately 7.9%), began an experiment in collaboration with Maccabi and the Medical Campus to validate the data reported by the RevDx device developed by it 31/01/2021 Read more Investors News CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation 10/02/2021 Globes: 32 million distribution agreement for Cardiacsens from Merchavia Group 08/06/2020 Buinees Today: Israel’s CardiacSense signs $32.4 million deal to sell medical watches in India 08/06/2020 Yahoo Finance: Israeli tech firm to sell $32.4 million in medical watches in India 07/06/2020 Read more Mail Alert Subscribe to Receive Notifications by Email: First Name Last Name Email Send Stock Price Tel Aviv: MRHL 93.9 Price -2.8% Change percentage -2.7 Change 92.9 90 Last Update:28/02/2021 at:13:45
Cardiacsense (approximately 5.67%), Receives CE approval for the marketing of a medical watch that it opened in Europe, expected date for FDA approval 10/02/2021
The investment of $ 150k as part of an investment round of about $ 17k in CDX according to about $ 112k (after), will hold 6.64% 07/02/2021
A round of fundraising in Cardiacsense (about 5.8%) – the debtor will invest $ 250, hold about 5.95% of the capital, B. Control will participate 04/02/2021
EFA (approximately 7.9%), began an experiment in collaboration with Maccabi and the Medical Campus to validate the data reported by the RevDx device developed by it 31/01/2021
CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation 10/02/2021
Buinees Today: Israel’s CardiacSense signs $32.4 million deal to sell medical watches in India 08/06/2020